Make your money go further for just 25p per day

IMMUNODIAGNOSTIC SYSTEMS HOLDINGS (AIM:IDH) – the expected excellent Interim Results

30/11/2010 · Immunodiagnostic Systems (IDH) 

The AIM quoted producer of diagnostic testing kits for the clinical and research markets, announced high flying interim results for the six month period to 30 September 2010.

IDH operate in the in-vitro diagnostics (“IVD”) market and designs, manufactures and sells immunoassay kits. These are used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies. In 2008 the company commented that the immunoassay sector of the IVD market was estimated to be worth US$14bn, a staggering number!

Revenue for the half year was up 34% to £22.6m, pre-tax…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Immunodiagnostic Systems

Coronavirus impact: 30 June - new Covid-19 test is great news

30/06/2020 · Company Insights

News today includes the launch of a new Covid-19 antibody test from an AIM quoted group…


Coronavirus impact: 17 June - Best of the Best receives takeover interest

17/06/2020 · Company Insights

Best of the Best announces a preliminary approach and boohoo continues to grow strongly over lockdown -…


More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP